Answer:
For a change in the environment that surrounds them.
Explanation:
Frogs and toads are amphibians that have the ability to live in both environments, that is why their respiratory system is highly adapted to extreme situations such as sudden climate changes, among others.
This modification of the environment many species would not tolerate because generally species always develop, live and reproduce in a single environment, such as humans, which is only in the terrestrial environment.
It is very difficult for frogs not to be able to adapt or survive climate change since they have the ability to adapt their respiratory system to two totally different media such as water and air.
Answer: Nucleotides
Explanation: DNA is made up of molecules called nucleotides. Each nucleotide contains a phosphate group, a sugar group and a nitrogen base. The four types of nitrogen bases are adenine (A), thymine (T), guanine (G) and cytosine (C).
If siRNA against a starch-branching enzyme was transmitted to humans, then it may affect the expression of glycogen-branching enzymes. RNAi inhibits gene expression.
Glycogen-branching enzymes are similar to starch-branching enzymes because glycogen bonds are similar to those observed between amylopectin.
The RNA interference (RNAi) pathway is an evolutionarily conserved mechanism used in molecular biology laboratories to inhibit the expression of target genes.
In the RNAi technique, a regulatory non-coding RNA called small interfering RNA (siRNA) that exhibits sequence complementary to the target gene sequence is used to inhibit and/or block the translation of the target mRNA (in this case, starch/glycogen-branching mRNA coding enzyme).
Learn more in:
brainly.com/question/11484135
Answer:
Monoclonal antibodies (mAbs) are produced by introducing an antigen to a mouse and then fusing polyclonal B cells from the mouse's spleen to myeloma cells. The resulting hybridoma cells are cultured and continue to produce antibodies to the antigen.
we use this for
:The use of monoclonal antibodies to treat diseases is called immunotherapy therapy because each type of monoclonal antibody will target a specific targeted antigen in the body. Uses for monoclonal antibodies include: Cancer. Rheumatoid arthritis.